Study endpoints
The primary endpoint was the occurrence of the composite of aortic valve intervention (including AVR or TAVR) or all-cause mortality between baseline and last follow-up. The secondary endpoints were the occurrence of cardiovascular mortality and AVR/TAVR between baseline and last follow-up.